Executive Officers
Harry A. Korman
President, North America
Harry A. (Hal) Korman serves Mylan as President, North America. He oversees the
growth and development of Mylan Pharmaceuticals Inc. (MPI), Mylan’s generics
business in the United States; Genpharm Inc., the former Canadian subsidiary of
Merck Generics and fourth largest generics company in Canada; and UDL
Laboratories Inc., the U.S. leader in unit dose packaging.
Mr. Korman previously held the positions of President of MPI and Senior Vice
President of Mylan Laboratories Inc. Since joining Mylan through its
acquisition of UDL Laboratories in 1996, he has served the Company in several
capacities of increasing responsibility including President of UDL and Vice
President of Sales and Marketing for MPI. He was a Sales Representative for
Berlex Laboratories Inc. for approximately eight years.
Mr. Korman earned a bachelor's of science in marketing/distributive education
from the University of Wisconsin.
Back to Executive Officers